Methods of treatment with stents with enhanced fracture toughness

US9522503B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9522503-B2
Application numberUS-201314086921-A
CountryUS
Kind codeB2
Filing dateNov 21, 2013
Priority dateJun 15, 2006
Publication dateDec 20, 2016
Grant dateDec 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Stents and methods of manufacturing a stents with enhanced fracture toughness are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating a blood vessel with a biodegradable stent comprising: deploying a biodegradable stent in a blood vessel from a crimped diameter to an intended deployment diameter, the biodegradable stent including a cylindrically-shaped scaffold comprising a poly(L-lactide)-based biodegradable polymer, wherein the scaffold includes a pattern comprising a plurality of cylindrical rings of struts and longitudinal linking struts connecting the rings, the scaffold formed by cutting the pattern in a tube, wherein the tube has been processed to increase crystallinity prior to cutting the pattern, the biodegradable polymer after the processing has a crystallinity of less than 50%, wherein the rings include bending elements, each bending element including struts that bend outward when the scaffold is deployed to allow for radial expansion of the scaffold, wherein curved portions of the bending elements have no cracks at the crimped diameter, wherein cracks form in the curved portions of the bending elements when the stent is deployed to the intended deployment diameter, wherein the bending elements have an angle greater than 90° at a diameter the pattern is cut, and wherein the scaffold has adequate radial strength to hold open the blood vessel. 2. The method of claim 1 , wherein the processing comprises radially expanding the tube to an expanded diameter prior to forming the pattern in the tube at the expanded diameter, the radial expansion providing induced molecular orientation in the circumferential direction in the scaffold. 3. The method of claim 1 , wherein the scaffold has induced molecular orientation in the circumferential direction. 4. The method of claim 1 , wherein the processing comprises heating the tube to a temperature above a glass transition temperature (Tg) of the biodegradable polymer. 5. The method of claim 1 , wherein the bending elements have an angle greater than 110° at the diameter the pattern is cut. 6. The method of claim 1 , wherein the biodegradable polymer after the processing has a crystallinity less than 40%. 7. The method of claim 1 , wherein the biodegradable polymer after the processing has a crystallinity less than 20%. 8. The method of claim 1 , wherein the stent is stored at ambient temperature until the treatment. 9. The method of claim 1 , wherein the crimped diameter is 0.055 in. 10. The method of claim 1 , wherein the intended deployment diameter is 0.158 in. 11. A method of treating a blood vessel with a biodegradable stent comprising: deploying a biodegradable stent in a blood vessel from a crimped diameter to an intended deployment diameter, the biodegradable stent including a cylindrically-shaped scaffold including a pattern of interconnected struts formed by cutting the pattern in a tube, wherein the scaffold comprises a poly(L-lactide)-based biodegradable polymer, the scaffold having a first end and a second end, wherein the tube has been processed to increase crystallinity prior to cutting, the biodegradable polymer after the processing has a crystallinity of less than 50%, wherein the pattern comprises a plurality of cylindrical rings of struts and longitudinal linking struts connecting the rings, wherein the rings include bending elements, each bending element including struts that bend outward when the scaffold is deployed to allow for radial expansion of the scaffold, each bending element comprising an apex, wherein cracks form in curved portions of the bending elements when the stent is deployed to the intended deployment diameter, wherein the bending elements comprise free bending elements, W-shaped bending elements, and Y-shaped bending elements, wherein the free bending elements are not directly connected to any adjacent ring, each W-shaped bending element is directly connected by one of the linking struts at a concave portion of the apex of the W-shaped bending element to a convex portion of an apex on an adjacent ring located in a direction of the first end, and each Y-shaped bending element is directly connected by one of the linking struts at a convex portion of the apex of the Y-shaped bending element to a concave portion of an apex on an adjacent ring located in a direction of the second end, wherein each of the apices of one of the rings is opposed to an apex on two adjacent rings, and the opposing apices are directed toward the same end of the scaffold, wherein the bending elements have an angle greater than 90° at a scaffold diameter that the pattern is cut, and wherein the scaffold has adequate radial strength to hold open the blood vessel. 12. The method of claim 11 , wherein the processing comprises radially expanding the tube to an expanded diameter prior to cutting the pattern in the tube at the expanded diameter, the radial expansion providing induced molecular orientation in the circumferential direction in the scaffold. 13. The method of claim 11 , wherein the scaffold has induced molecular orientation in the circumferential direction. 14. The method of claim 11 , wherein the processing comprises heating the tube to a temperature above a glass transition temperature (Tg) of the biodegradable polymer. 15. The method of claim 11 , wherein the bending elements have an angle greater than 110°. 16. The method of claim 11 , wherein the biodegradable polymer after the processing has a crystallinity less than 40%. 17. The method of claim 11 , wherein the biodegradable polymer after the processing has a crystallinity less than 20%. 18. The method of claim 11 , wherein the stent is stored at ambient temperature until the treatment. 19. The method of claim 11 , wherein a repeating sequence of bending elements in each of the rings is free bending element, followed by Y-shaped bending element, followed by free bending element, and followed by W-shaped bending element. 20. The method of claim 11 , wherein the curved portions of the bending elements have no cracks at the crimped diameter.

Assignees

Inventors

Classifications

  • using gas or flames · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

  • connected trough to trough · CPC title

  • Means for mounting a stent or stent-graft onto or into a placement instrument · CPC title

  • made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9522503B2 cover?
Stents and methods of manufacturing a stents with enhanced fracture toughness are disclosed.
Who is the assignee on this patent?
Abbott Cardiovascular Systems Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/915. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).